Critical Outcome Technologies Strengthens Its Board
Marketwired - Thu May 14, 7:30AM CDT
Critical Outcome Technologies Inc. ("COTI" or the "Company"
COT.VN: 0.270 (-0.010)
HIV-1 Infection - Pipeline Review, H1 2015
M2 - Wed May 13, 5:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wrjl97/hiv1_infection) has announced the addition of the "HIV-1 Infection - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for HIV-1 Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for HIV-1 Infection and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - AlphaVax, Inc. - AltraVax Inc. - Aphios Corporation - Argos Therapeutics, Inc. - Bionor Pharma ASA - Biosantech SA - Boehringer Ingelheim GmbH - Bristol-Myers Squibb Company - CompleGen, Inc. - Critical Outcome Technologies Inc. - CytoDyn Inc. - Enzo Biochem, Inc. - FIT Biotech Oy - GeneCure LLC - Gilead Sciences, Inc. - GlaxoSmithKline plc - Heat Biologics, Inc. - InnaVirVax SA - Inovio Pharmaceuticals, Inc. - Johnson & Johnson - Merck & Co., Inc. - Mymetics Corporation - Myrexis, Inc. - Oncovir, Inc. - OyaGen Inc. - Peregrine Pharmaceuticals, Inc. - Pfizer Inc. - Pharis Biotec GmbH - United Biomedical, Inc. - Valens Therapeutics, Inc. - Vichem Chemie Research Ltd. - ViiV Healthcare Limited For more information visit http://www.researchandmarkets.com/research/wr..._infection
HTBX: 5.77 (-0.40), PFE: 33.99 (+0.05), BMY: 67.64 (+0.19), GSK: 44.77 (-0.22), ARGS: 7.68 (+0.09), INO: 7.97 (-0.02), JNJ: 102.30 (+0.47), ENZ: 2.50 (unch), GILD: 109.30 (+0.56), MRK: 60.23 (+0.45)
Critical Outcome Technologies Adds First European Patent to Growing Intellectual Property Protection for COTI-2
Marketwired - Mon May 11, 7:31AM CDT
Critical Outcome Technologies Inc. ("COTI" or the "Company"
COT.VN: 0.270 (-0.010)
Critical Outcome Technologies Files Investigational New Drug Application With the FDA for COTI-2
Marketwired - Mon Apr 27, 7:31AM CDT
Critical Outcome Technologies Inc. ("COTI" or the "Company"
COT.VN: 0.270 (-0.010)
Critical Outcome Technologies Receives First U.S. Patent for Next Generation HIV Treatment
Marketwired - Wed Apr 15, 7:30AM CDT
Critical Outcome Technologies Inc. ("COTI" or the "Company"
COT.VN: 0.270 (-0.010)
Critical Outcome Technologies Inc. Strengthens Its Investor Relations Outreach
Marketwired - Thu Apr 02, 8:01AM CDT
Critical Outcome Technologies Inc. (TSX VENTURE: COT) (OTCQB: COTQF) ("COTI" or the "Company"
COT.VN: 0.270 (-0.010)
Critical Outcome Technologies Establishes Advisory Board for the Clinical Development of COTI-2
Marketwired - Mon Mar 23, 7:30AM CDT
Critical Outcome Technologies Inc. (TSX VENTURE: COT) (OTCQB: COTQF) ("COTI" or the "Company"
COT.VN: 0.270 (-0.010)
Critical Outcome Technologies Reports Fiscal 2015 Third Quarter Results
Marketwired - Fri Mar 20, 3:05PM CDT
Critical Outcome Technologies Inc. (TSX VENTURE: COT) (OTCQB: COTQF) ("COTI" or the "Company"
COT.VN: 0.270 (-0.010)
Critical Outcome Provides Update on COTI-2 IND Filing
Marketwired - Mon Mar 02, 8:33AM CST
Critical Outcome Technologies Inc. (TSX VENTURE: COT) (OTCQB: COTQF) ("COTI" or the "Corporation"
COT.VN: 0.270 (-0.010)
Critical Outcome Technologies Closes Private Placement
Marketwired - Wed Feb 18, 7:30AM CST
Critical Outcome Technologies Inc. (TSX VENTURE: COT) (OTCQB: COTQF) ("COTI" or the "Corporation"
COT.VN: 0.270 (-0.010)
Critical Outcome Technologies Planning Phase 1 Clinical Trial of COTI-2 in Recurrent Head and Neck Cancers
Marketwired - Tue Jan 20, 8:05AM CST
Critical Outcome Technologies Inc. ("COTI" or the "Company"
COT.VN: 0.270 (-0.010)